COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study
- PMID: 35318432
- PMCID: PMC8940902
- DOI: 10.1038/s41598-022-08947-x
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study
Abstract
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID-19 on LT recipients compared to general population in the Campania region. In this prospective double-centre study, we enrolled all consecutive adult LT recipients with confirmed SARS-CoV-2-infection. Data were collected at diagnosis of COVID-19 and during follow-up and compared with the regional population. Thirty LT recipients (3.28%) developed SARS-CoV-2-infection (76.66% male, median age 62.61 years). Sixteen (53.33%) were symptomatic. Common symptoms were fever, cough, fatigue, and anosmia. Twenty-five (83.33%) were outpatients, 5 (16.66%) required hospitalization (6.66% admitted to Intensive Care Unit, 6.62% developed Acute Respiratory Distress Syndrome and 6.66% died). Immunosuppressors were in 3 (10%) patients. Incidence rate of COVID-19 was similar between LT patients and general population (3.28% vs 4.37%, p = 0.142) with higher rate of symptoms in LT patients (53.33% vs 15.87%, p < 0.000). At univariate analysis, hospitalization and case fatality rates were higher in LT patients compared to general population (16.66% vs 4.54%, p = 0.001; and 6.66% vs 1.76%, p = 0.041, respectively). At multivariable logistic regression analysis, LT patients with COVID-19 were more frequently symptomatic (OR 5.447 [95% CI 2.437-12.177], p < 0.000), whereas hospitalization and death for COVID-19 were not significatively associated with LT condition (p = 0.724 and p = 0.462, respectively) and were comparable with general population. LT is not a risk factor for acquiring COVID-19. Nonetheless, LT patients are more frequently symptomatic, although comparable to the general population for hospitalization rate and mortality.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28. Lancet Gastroenterol Hepatol. 2020. PMID: 32866433 Free PMC article.
-
SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study.Transplant Proc. 2021 May;53(4):1112-1117. doi: 10.1016/j.transproceed.2020.11.009. Epub 2020 Dec 16. Transplant Proc. 2021. PMID: 33451759 Free PMC article.
-
Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study.Gastroenterology. 2021 Mar;160(4):1151-1163.e3. doi: 10.1053/j.gastro.2020.11.045. Epub 2020 Dec 9. Gastroenterology. 2021. PMID: 33307029 Free PMC article.
-
SARS-CoV-2 infection in adult liver transplantation recipients: a systematic review of risk factors for mortality and immunosuppression role.Eur Rev Med Pharmacol Sci. 2023 Feb;27(4):1695-1707. doi: 10.26355/eurrev_202302_31413. Eur Rev Med Pharmacol Sci. 2023. PMID: 36876704
-
COVID-19 in hospitalized liver transplant recipients: An early systematic review and meta-analysis.Clin Transplant. 2021 Apr;35(4):e14246. doi: 10.1111/ctr.14246. Epub 2021 Feb 25. Clin Transplant. 2021. PMID: 33555058 Free PMC article.
Cited by
-
Effect of COVID-19 Pandemic on Patients Who Have Undergone Liver Transplantation: Retrospective Cohort Study.J Clin Med. 2023 Jul 3;12(13):4466. doi: 10.3390/jcm12134466. J Clin Med. 2023. PMID: 37445501 Free PMC article.
-
Liver transplantation amidst the COVID-19 era: Our center's experience.World J Clin Cases. 2023 Jan 16;11(2):316-321. doi: 10.12998/wjcc.v11.i2.316. World J Clin Cases. 2023. PMID: 36686357 Free PMC article. Review.
-
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients.J Hepatol. 2023 May;78(5):1017-1027. doi: 10.1016/j.jhep.2023.02.007. Epub 2023 Feb 18. J Hepatol. 2023. PMID: 36804404 Free PMC article.
-
Impact of COVID-19 on liver transplant recipients: A nationwide cohort study evaluating hospitalization, transplant rejection, and inpatient mortality.World J Transplant. 2024 Jun 18;14(2):90866. doi: 10.5500/wjt.v14.i2.90866. World J Transplant. 2024. PMID: 38947960 Free PMC article.
-
Successful liver transplantation in patients with active SARS-CoV-2 infection.Am J Transplant. 2022 Nov;22(11):2694-2696. doi: 10.1111/ajt.17134. Epub 2022 Jul 9. Am J Transplant. 2022. PMID: 35776656 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous